Replimune Group, Inc. (REPL) Tops Q1 EPS by 8c

Replimune Group, Inc. (NASDAQ: REPL) reported Q1 EPS of ($0.78), $0.08 better than the analyst estimate of ($0.86).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• Morgan Stanley Upgrades CDW Corporation (CDW) to Overweight
• Taysha Gene Therapies (TSHA) PT Raised to $11 at Citizens on REVEAL Data Update